2024 Publications
Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand. View article. Hayley Barnes, Tamera J Corte, Gregory Keir, Yet H Khor, Sandhya Limaye, Jeremy P Wrobel, Elizabeth Veitch, John Harrington, Leona Dowman, Lutz Beckert, David Milne, Rebekah De Losa, Wendy A Cooper, Peter T Bell, Pradeep Balakrishnan, Lauren K Troy. 2024. Respirology.
Silicosis—Where to from here? View article. Hayley Barnes, Dan Chambers. 2024. Respirology.
Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis. View article. B Guillen-Guio, ML Paynton, RJ Allen, DPW Chin, LJ Donoghue, A Stockwell, OC Leavy, T Hernandez-Beeftink, C Reynolds, P Cullinan, F Martinez, HL Booth, WA Fahy, IP Hall, SP Hart, MR Hill, N Hirani, RB Hubbard, RJ McAnulty, AB Millar, V Navaratnam, E Oballa, H Parfrey, G Saini, I Sayers, MD Tobin, MKB Whyte, A Adegunsoye, N Kaminski, S-F Ma, ME Strek, Y Zhang, TE Fingerlin, M Molina-Molina M, M Neighbors, XR Sheng, JM Oldham, TM Maher, PL Molyneaux, C Flores, I Noth, DA Schwartz, BL Yaspan, RG Jenkins, LV Wain, EJ Hollox. 2024. ERJ Open Research.
A self-management package for pulmonary fibrosis: A feasibility study. View article. JYT Lee, G Tikellis, M Hoffman, CR Mellerick, K Symons, J Bondarenko, YH Khor, I Glaspole, AE Holland. 2024. PEC Innovation.
Telerehabilitation: a key player in reducing the travel emissions cost of respiratory healthcare? View article. M Chong, AE Holland, AT Burge, J Perryman, NS Cox. 2024. European Respiratory Journal.
The Analysis of Proteomics by Machine Learning in Separating Idiopathic Pulmonary Fibrosis from Connective Tissue Disease–Interstitial Lung Disease. View article. Y Moodley. 2024. American Journal of Respiratory and Critical Care Medicine.
Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations An Official American Thoracic Society Clinical Practice Guideline. View article. G Raghu, M Ghazipura, SB Montesi, RM Silver, T Hossain, M Macrea, D Herman, H Barnes, A Adegunsoye, A Azuma, D Burlile, L Chung, GC Gardner, KB Highland, M Hudson, RJ Kaner, KA Kemper, SL Knight, M Kolb, MB Scholand, V Steen, CC Thomson, ER Volkmann, FM Wigley. 2024. American Journal of Respiratory and Critical Care Medicine.
Large airway wall vascularity in patients with asthma–COPD overlap: a bronchoscopy study. View article. S Dey, W Lu, HC Weber, C Chia, PS Pathinayake, PAB Wark, MS Eapen, SS Sohal. 2024. ERJ Open Research.
Mycophenolate in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis. View article. D Herman, M Ghazipura, H Barnes, M Macrea, SL Knight, RM Silver, SB Montesi, G Raghu, T Hossain. 2024. Annals of the American Thoracic Society.
Multi-omics integration reveals a nonlinear signature that precedes progression of lung fibrosis. View article. C Pattaroni, C Begka, B Cardwell, J Jaffar, N Macowan, NL Harris, GP Westall, BJ Marsland. 2024. Clinical and Translational Immunology.
Pulmonary rehabilitation in idiopathic pulmonary fibrosis. View article. LM Dowman, AE Holland. 2024. Current Opinion in Pulmonary Medicine.
Scoping review of exposure questionnaires and surveys in interstitial lung disease. View article. H Barnes, S Elmrayed, CM Barber, J Feary, CT Lee, S Gandhi, CE Peters, ML Salisbury, KA Johannson. 2024. BMJ Open Respiratory Research.
Genetics and Genomics of Pulmonary Fibrosis Charting the Molecular Landscape and Shaping Precision Medicine. View article. A Adegunsoye, JA Kropski, J Behr, TS Blackwell, TJ Corte, V Cottin, AR Glanville, MK Glassberg, M Griese, GM Hunninghake, KA Johannson, MP Keane, JS Kim, M Kolb, TM Maher, JM Oldham, AJ Podolanczuk, IO Rosas, FJ Martinez, I Noth, DA Schwartz. 2024. American Journal of Respiratory and Critical Care Medicine.
A systematic review of procedural and sampling techniques for cryobiopsy in interstitial lung disease. View article. JA Lachowicz, NE Smallwood, JD Prasad, P Patel, C Voutier, YH Khor, DP Steinfort. 2024. European Respiratory Review.
Cyclophosphamide in Patients with Systemic Sclerosis-associated Interstitial Lung Disease A Systematic Review and Meta-Analysis. View article. H Barnes, M Ghazipura, D Herman, M Macrea, SL Knight, RM Silver, SB Montesi, G Raghu, T Hossain. 2024. Annals of the American Thoracic Society.
Tocilizumab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis. View article. M Ghazipura, M Macrea, D Herman, H Barnes, SL Knight, RM Silver, SB Montesi, G Raghu, T Hossain. 2024. Annals of the American Thoracic Society.
Contemporary Concise Review 2023: Interstitial lung disease. View article. Y Moodley. 2024. Respirology.
The 1-min sit-to-stand test as a screening tool to assess exercise-induced oxygen desaturation in normoxemic people with interstitial lung disease. View article. S Visser, C Lawler, CC Fermoyle, LM Spencer, AJ McAnulty, JA Alison, S Webster, L Troy, H Jo, A Hayen, TJ Corte. 2024. Respiratory Medicine.
Nintedanib Therapy Alone and Combined with Mycophenolate in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: Systematic Reviews and Meta-analysis. View article. M Macrea, M Ghazipura, D Herman, H Barnes, SL Knight, RM Silver, SB Montesi, G Raghu T Hossain. 2024. Annals of the American Thoracic Society.
Clinically important changes and adverse events with centre-based or home-based pulmonary rehabilitation in chronic respiratory disease: A systematic review and meta-analysis. View article. J Bondarenko, S Dal Corso, MP Dillon, S Singh, BR Miller, C Kein, AE Holland, AW Jones. 2024. Chronic Respiratory Disease.
Rituximab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis. View article. M Macrea, M Ghazipura, D Herman, H Barnes H, SL Knight, RM Silver, SB Montesi, G Raghu, T Hossain. 2024. Annals of the American Thoracic Society.
The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions. View article. J Behr, ML Salisbury, SLF Walsh, AJ Podolanczuk, LP Hariri, GM Hunninghake, M Kolb, CJ Ryerson, V Cottin, MB Beasley, T Corte, AR Glanville, A Adegunsoye, C Hogaboam, WA Wuyts, I Noth, JM Oldham, L Richeldi, G Raghu, AU Wells. 2024. American Journal of Respiratory and Critical Care Medicine.
Unsupervised Exercise in Interstitial Lung Disease: A Delphi Study to Develop a Consensus Preparticipation Screening Tool for Lymphangioleiomyomatosis. View article. CE Child, LA Ho, D Lachant, N Gupta, J Moss, A Jones, R Krishn, AE Holland, MK Han, C McCarthy, A Ataya, M Baqir, DF Dilling, J Swigris, ER Swenson, MB Brown. 2024. Chest.
Cyclophosphamide in Patients with Systemic Sclerosis-associated Interstitial Lung Disease A Systematic Review and Meta-Analysis. View article. H Barnes, M Ghazipura, D Herman, M Macrea, SL Knight, RM Silver, SB Montesi, G Raghu G, T Hossain. 2024. Annals of the American Thoracic Society
Efficacy and Safety of Admilparant, an LPA1 Antagonist in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial. View article. Tamera J Corte, Juergen Behr, Vincent Cottin, Marilyn K Glassberg, Michael Kreuter, Fernando J Martinez, Takashi Ogura, Takafumi Suda, Marlies Wijsenbeek, Elchonon Berkowitz, Brandon Elpers, Sinae Kim, Hideaki Watanabe, Aryeh Fischer, Toby M Maher. 2024. American Journal of Respiratory and Critical Care Medicine.
Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease. View article. Andrew Li, Alan Teoh, Lauren Troy, Ian Glaspole, Margaret L Wilsher, Sally de Boer, Jeremy Wrobel, Yuben P Moodley, Francis Thien, Henry Gallagher, Michelle Galbraith, Daniel C Chambers, John Mackintosh, Nicole Goh, Yet Hong Khor, Adrienne Edwards, Karen Royals, Christopher Grainge, Benjamin Kwan, Gregory Keir, Chong Ong, Paul Reynolds, Elizabeth Veitch, Gin Tsen Chai, Ziqin Ng, Geak Poh Tan, Dan Jackson, Tamera Corte, Helen Jo. 2024. Thorax.
Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation. View article. Hernan P Fainberg, Yuben Moodley, Isaac Triguero, Tamera J Corte, Jannie M B Sand, Diana J Leeming, et al. 2024. The Lancet Respiratory Medicine.
Steroid therapy in acute exacerbation of fibrotic interstitial lung disease. View article. Koshy K, Barnes H, Farrand E, Glaspole I. 2024. Respirology.
Impact of Test Instructions on 6-min Walk Distance in Adults with Chronic Respiratory Disease: A Randomized Controlled Trial. View article. CR Mellerick, AT Burge, CJ Hill, NS Cox, J Bondarenko, AE Holland. 2024. Journal of Cardiopulmonary Rehabilitation and Prevention.
Exertional Desaturation During the 6-Minute Walk Test vs Daily Life in People With Fibrotic Interstitial Lung Disease. View article. M Hoffman, AT Burge, N Wong, CF McDonald, DC Chambers, I Glaspole, JA Mackintosh, M Ekström, M Sköld, NSL Goh, TJ Corte, AE Holland. 2024. Chest.
Using change in 6-minute walk distance to predict survival in progressive pulmonary fibrosis: A promising measure in need of precision. View article. AE Holland, L Dowman. 2024. Respirology.
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. View article. JA Mackintosh, DC Chambers. 2024. European Respiratory Journal.
Disease Behaviour Classification: A pragmatic model for predicting outcomes in Interstitial Lung Disease. View article. M Harrison, HE Jo, LK Troy, B Nguyen, SE Webster, M Geis, S Lai, E Mulyadi, WA Cooper, A Mahar, A Teoh, A Jee, TJ Corte. 2024. Respiratory Medicine.
Reply to: Optimal clinical practice in IPF and PPF: Integrating scientific ethos and clinical reasoning. View article. JA Mackintosh, G KeiR, TJ Corte. 2024. Respirology.
Editorial: Epidemiology and risk factors for interstitial lung diseases. View article. N Jeganathan, TJ Corte, P Spagnolo. 2024. Frontiers in Medicine.
Respiratory teletrials—A call for equitable access to clinical trials for people with respiratory conditions. View article. AE Holland, A Woollett, N Goh, I Glaspole. 2024. Respirology.
Drug-induced interstitial lung disease: a narrative review of a clinical conundrum. View article. M HarrisoN, G Kavanagh, TJ Corte, LK Troy. 2024. Expert Review of Respiratory Medicine.
Unravelling the health and economic burden of interstitial lung diseases in adults in Australia. View article. IA Cox, BD Graaff, Q Zheng, TJ Corte, EH Walters, AJ Palmer. 2024. Australian Journal of General Practice.
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. View article. JA Mackintosh, G Keir, LK Troy, AE Holland, C Grainge, DC Chambers, D Sandford, HE Jo, I Glaspole, M Wilsher, NSL Goh, PN Reynolds, S Chapman, S Mutsaers, S de Boer, S Webster, Y Moodley, TJ Corte. 2024. Respirology.
Summary for Clinicians: Clinical Practice Guideline on Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease. View article. AR Jenkins, NS Cox, RS Tappan, AE Holland, CL Rochester, JA Alison, B Carlin, JK Ruminjo, CC Thomson. 2024. Annals of the American Thoracic Society.
Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis The Randomized Phase III STARSCAPE Trial. View article. L Richeldi, C Schiffman, J Behr, Y Inoue, TJ Corte, V CottiN, RG Jenkins, SD Nathan, G Raghu, SLF Walsh, PK Jayia, N Kamath, FJ Martinez. 2024. American Journal of Respiratory and Critical Care Medicine.
A novel therapy for intractable chronic cough. View article. M Bricknell, CZ-F Zhao, N Smallwood, N Goh. 2024. Respirology Case Reports.
High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study. View article. Desai SR, Sivarasan N, Johannson KA, George PM, Culver DA, Devaraj A, Lynch DA, Milne D, Renzoni E, Nunes H, Sverzellati N, Spagnolo P, Baughman RP, Yadav R, Piciucchi S, Walsh SLF, Kouranos V, Wells AU, Anderson A, Morgenthau A, Gaser A, Vizel A, Speranskaya A, Gerke A, Goksel A, Undurraga A, Sharma A, Oh A, Leung A, Larici AR, Prasse A, Mazzei A, Morais A, Bhalla A, Del Rio B, Jankharia B, Elicker B, Pereira C, Biegelman-Aubry C, White C, Ravaglia C, Hsia C, Schaefer-Prokop C, Launay D, Talwar D, Castillo D, Patel D, Israel-Biet D, Valeyre D, Britt EJ, Bargagli E, Bendstrup E, Crouser E, Nossent E, Shmelev E, Porquera EC, Bonella F, Cohen-Aubart F, Jeny F, Ferrara G, Jin GY, Robbie H, Prosch H, Sumikawa H, Ling-Pei H, Lee HY, Strambu I, Buendia-Roldan I, Grutters J, Ryu J, Swigris J, Miedema J, Goo JM, Barnett J, Verschakelen J, Goldin J, Seo JB, Enghelmayer J, Mana J, Behr J, Patterson K, Antoniou K, Brown K, Fujimoto K, Savale L, Maier L, Richeldi L, Neto MLR, Humbert M, Judson M, Veltkamp M, Wilsher M, Molina M, Otaola M, Revel M-P, Silva M, Drent M, Schiebler M, Wijsenbeek-Lourens M, Bonifazi M, Remy-Jardin M, Koslow M, Balter M, Kreuter M, Thillai M, Hamzeh N, Chaudhuri N, Mogulkoc N, Todd N, Screaton N, Goh N, Shah N, Obi O, Shlobin O, Baranova O, Bresser P, Rottoli P, Brillet P-Y, Said-Hartley Q, Borie R, Mostard R, van Zyl-smit R, Kairalla R, Egashira R, Boussouar S, Lee S.M, Bhalla S, Tomassetti S, Quadrelli S, Hart SP, Danoff S, Rajan S, Choi SM, Copley S, Kim TJ, Johkoh T, Corte T, McLoud T, Wessendorf T, Alfaro T, Arai T, Costabel U, Vicens-Zygmunt V, Poletti V, Cottin V, Vucinic V, Wuyts W, van Es W, Jeong YJ, Inoue Y. 2024. The Lancet Respiratory Medicine.
Use of infection control measures in people with chronic lung disease: mixed methods study. View article. AW Jones, BE King, A Cumella, NS Hopkinson, JR Hurst, AE Holland. 2024. ERJ Open Research.
Treatable traits models of care. View article. VM McDonald, AE Holland. 2024. Respirology.
Exploring the anti-inflammatory and anti-fibrotic activity of NFκB decoy oligodeoxynucleotide-loaded spermine-functionalized acetalated nanoparticles. View article. G De Rubis, A Chakraborty, KR Paudel, C Wang, V Kannaujiya, P Wich, PM Hansbro, CS Samuel, B Oliver, K Dua. 2024. Chemico-Biological Interactions.
Navigating the COVID-19 pandemic: Experiences and self-management approaches adopted by people with interstitial lung disease. View article. Tikellis G, Corte T, Glaspole IN, Goh NSL, Khor YH, Wrobel J, Symons K, Fuhrmeister L, Glenn L, Chirayath S, Troy LK, King B, Holland AE. Chronic Respiratory Disease.
Mortality surrogates in combined pulmonary fibrosis and emphysema. View article. Zhao A, Gudmundsson E, Mogulkoc N, van Moorsel C, Corte TJ, Vasudev P, Romei C, Chapman R, Wallis TJM, Denneny E, Goos T, Savas R, Ahmed A, Brereton CJ, van Es HW, Jo H, De Liperi A, Duncan M, Pontoppidan K, De Sadeleer LJ, van Beek F, Barnett J, Cross G, Procter A, Veltkamp M, Hopkins P, Moodley Y, Taliani A, Taylor M, Verleden S, Tavanti L, Vermant M, Nair A, Stewart I, Janes SM, Young AL, Barber D, Alexander DC, Porter JC, Wells AU, Jones MG, Wuyts WA, Jacob J. 2024. European Respiratory Journal.
TGF-β1, pSmad-2/3, Smad-7, and β-Catenin Are Augmented in the Pulmonary Arteries from Patients with Idiopathic Pulmonary Fibrosis (IPF): Role in Driving Endothelial-to-Mesenchymal Transition (EndMT). View article. Archana Vijay Gaikwad, Mathew Suji Eapen, Surajit Dey, Prem Bhattarai, Affan Mahmood Shahzad, Collin Chia, Jade Jaffar, Glen Westall, Darren Sutherland, Gurpreet Kaur Singhera, Tillie-Louise Hackett, Wenying Lu and Sukhwinder Singh Sohal. 2024. Journal of Clinical Medicine.
Platelet Activating Factor Receptor and Intercellular Adhesion Molecule-1 Expression Increases in the Small Airway Epithelium and Parenchyma of Patients with Idiopathic Pulmonary Fibrosis: Implications for Microbial Pathogenesis. View article. Shahzad AM, Lu W, Dey S, Bhattarai P, Gaikwad AV, Jaffar J, Westall G, Sutherland D, Singhera GK, Hackett TL, Eapen MS, Sohal SS. 2024. Journal of Clinical Medicine.